4 transcripts
NTRA
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
.
In addition, Solomon will provide an update on organ health and some recent news on Prospera and Renasight. He will discuss a major win with the new consensus
NTRA
Earnings call transcript
NASDAQ
2024 Q1
9 May 24
quarter across the board, and I'm very pleased to share that we met a major milestone in the life cycle of the company and reaching cash flow breakeven
NTRA
Earnings call transcript
NASDAQ
2023 Q4
28 Feb 24
in 2024. This includes major investments in core product enhancements and line extensions plus potentially guideline enabling clinical trials that we
NTRA
Earnings call transcript
NASDAQ
2023 Q2
3 Aug 23
significantly, with the majority of the outperformance driven by growth in Signatera clinical and also pharma. We also saw women's health revenues
- Prev
- 1
- Next